ORIGINAL RESEARCH article

Front. Cell Dev. Biol.

Sec. Cell Growth and Division

Volume 13 - 2025 | doi: 10.3389/fcell.2025.1589034

This article is part of the Research TopicCellular Senescence in Aging-Related Diseases: Mechanisms and Therapeutic TargetsView all articles

Systematic Optimization of Prime Editing for Enhanced Efficiency and Versatility in Genome Engineering Across Diverse Cell Types

Provisionally accepted
  • 1School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China
  • 2Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, Shanghai Municipality, China
  • 3University of Chinese Academy of Sciences, Beijing, China
  • 4School of Pharmacy, Henan University, Kaifeng, China

The final, formatted version of the article will be published soon.

Prime editing offers remarkable versatility in genome editing, but its efficiency remains a major bottleneck. While continuous optimization of the prime editing enzymes and guide RNAs (pegRNAs) has improved editing outcomes, the method of delivery also plays a crucial role in overall performance. To maximize prime editing efficiency, we implemented a series of systematic optimizations, achieving up to 80% editing efficiency across multiple loci and cell lines. Beyond integrating the latest advancements in prime editing, our approach combined stable genomic integration of prime editors via the piggyBac transposon system, selection of integrated single clones, the use of an enhanced promoter, and lentiviral delivery of pegRNAs, ensuring robust, ubiquitous, and sustained expression of both prime editors and pegRNAs. To further assess its efficacy in challenging cell types, we validated our optimized system in human pluripotent stem cells (hPSCs) in both primed and naï ve states, achieving substantial editing efficiencies of up to 50%. Collectively, our optimized prime editing strategy provides a highly efficient and versatile framework for genome engineering in vitro, serving as a roadmap for refining prime editing technologies and expanding their applications in genetic research and therapeutic development.

Keywords: Prime Editing, PiggyBac transposon system, Pluripotent Stem Cells, sustained expression, genome engineering

Received: 06 Mar 2025; Accepted: 17 Apr 2025.

Copyright: © 2025 Zhao, Mu, Liu, Chi, Wang, Meng, Zhang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dongxin Zhao, School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more